In summary, the pro-tumor effects of IgA include: 1) IgA inhibits CD8+ T cell function through the expression of PD-L1 and IL-10 and activates inflammatory pathways; 2) Interaction with CAFs enhances immunosuppressive properties and weakens anti-tumor responses. This evidence concerns the gene CD79A and neoplasm.